产品编号 | bs-10260R |
英文名称 | BCAS4 |
中文名称 | 乳腺癌扩增序列蛋白4抗体 |
别 名 | BCAS4; BCAS4/BCAS3 fusion; BCAS4_HUMAN; Breast carcinoma amplified sequence 4; Breast carcinoma amplified sequence 4/3 fusion protein; Breast carcinoma-amplified sequence 4; CNOL. |
研究领域 | 肿瘤 免疫学 |
抗体来源 | Rabbit |
克隆类型 | Polyclonal |
交叉反应 | (predicted: Human) |
产品应用 | IHC-P=1:100-500, IHC-F=1:100-500, ICC=1:100-500, IF=1:100-500, ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
理论分子量 | 23kDa |
细胞定位 | 细胞浆 |
性 状 | Liquid |
浓 度 | 1mg/ml |
免 疫 原 | KLH conjugated synthetic peptide derived from human BCAS4: 61-160/211 |
亚 型 | IgG |
纯化方法 | affinity purified by Protein A |
缓 冲 液 | Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4 |
保存条件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
产品介绍 |
BCAS4 (Breast Carcinoma Amplified Sequence 4) is a Protein Coding gene. Diseases associated with BCAS4 include choanal atresia. An important paralog of this gene is BLOC1S4.
BCAS4 A chromosomal aberration involving BCAS4 has been found in some breast carcinoma cell lines. Translocation t(17;20)(q23;q13) with BCAS3. Belongs to the cappuccino family. 3 isoforms of the human protein are produced by alternative splicing. Subcellular Location: Cytoplasm Tissue Specificity: Brain, thymus, spleen, kidney and placenta. Overexpressed in most breast cancer cell lines. DISEASE: A chromosomal aberration involving BCAS4 has been found in some breast carcinoma cell lines. Translocation t(17;20)(q23;q13) with BCAS3. SWISS: Q8TDM0 Gene ID: 55653 Database links: Entrez Gene: 55653 Human Omim: 607471 Human SwissProt: Q8TDM0 Human Unigene: 381178 Human |
1、抗体溶解方法 | |
2、抗体修复方式 | |
3、常用试剂的配制 | |
4、免疫组化操作步骤 | |
5、免疫组化问题解答 | |
6、Western Blotting 操作步骤 | |
7、Western Blotting 问题解答 | |
8、关于肽链的设计 | |
9、多肽的溶解与保存 | |
10、酶标抗体效价测定程序 | |